Telix Pharmaceuticals Limited (TLX)

Telix Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	10.84	30.89	3.55	-70.74	-58.54	-34.63
Depreciation & Amortization	12.4	4.96	4.6	3.66	3.76	3.77
Asset Writedown & Restructuring Costs	-0.5	-0.48	0.55	-	-	-
Stock-Based Compensation	12.89	12.17	5.99	5.51	0.96	1.81
Other Operating Activities	29.13	18.86	24.43	18.77	12.59	6.02
Change in Accounts Receivable	-37.42	-35.32	-18.67	-13.55	-5.23	-0.25
Change in Inventory	-2.12	-2	-6.57	-3.41	-2.05	-0.07
Change in Accounts Payable	28.78	27.17	19.99	20.7	5.44	1.29
Change in Unearned Revenue	-6.13	-5.79	-3.61	-1.91	-1.96	23.72
Change in Other Net Operating Assets	-25.24	-23.83	-13.99	-2.51	1.89	-0.15
Operating Cash Flow	22.63	26.63	16.28	-43.48	-43.14	1.51
Operating Cash Flow Growth	-25.62%	63.56%	-	-	-	-
Capital Expenditures	-12.99	-8.86	-6.6	-4.78	-0.97	-0.19
Cash Acquisitions	-236.85	-21.47	-1.01	-0.66	-	-0.25
Sale (Purchase) of Intangibles	-22.33	-12.2	-0.76	-4.64	-	-0.06
Investment in Securities	-33.61	-32.17	-8.97	-	-	-
Other Investing Activities	-11.27	-8.95	-0.04	-1.47	-1.01	-0.34
Investing Cash Flow	-317.04	-83.65	-17.37	-11.55	-1.98	-0.84
Long-Term Debt Issued	-	405.93	3.92	2.05	-	-
Long-Term Debt Repaid	-	-1.94	-1.51	-0.87	-0.68	-0.7
Net Debt Issued (Repaid)	423.39	403.99	2.41	1.18	-0.68	-0.7
Issuance of Common Stock	0.91	0.62	4.53	123.05	2.75	27.12
Other Financing Activities	-9.76	-9.21	-	-5.31	-	-0.1
Financing Cash Flow	414.54	395.4	6.94	118.92	2.07	26.32
Foreign Exchange Rate Adjustments	37.23	24.96	-1.14	0.2	2.4	-1.26
Net Cash Flow	157.35	363.33	4.71	64.09	-40.65	25.73
Free Cash Flow	9.64	17.77	9.68	-48.26	-44.11	1.32
Free Cash Flow Growth	-57.93%	83.47%	-	-	-	-
Free Cash Flow Margin	1.45%	3.67%	2.83%	-44.35%	-798.67%	32.84%
Free Cash Flow Per Share	0.04	0.05	0.03	-0.15	-0.16	0.01
Cash Interest Paid	8.55	2.93	0.54	0.28	0.14	0.15
Cash Income Tax Paid	0.69	1.74	6.99	-11.3	-8.81	-8.8
Levered Free Cash Flow	13.73	54.01	42.88	-20.88	-27.18	-12.76
Unlevered Free Cash Flow	20.38	56.81	43.21	-20.74	-27.11	-12.67
Change in Working Capital	-42.14	-39.77	-22.84	-0.68	-1.91	24.54

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q